Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Padagis US LLC

NDC labeler code: 0574

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

50Products (NDC)

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
February 26, 2026ANDA220454 Phytonadione
PHYTONADIONE
Novax
September 30, 2025ANDA216001 Tofacitinib
TOFACITINIB CITRATE
Sinotherapeutics Inc
January 29, 2025ANDA215204 Loteprednol etabonate
LOTEPREDNOL ETABONATE
Padagis Us
July 10, 2024ANDA215203 Loteprednol etabonate
LOTEPREDNOL ETABONATE
Padagis Us
February 22, 2024ANDA217265 Lenalidomide
LENALIDOMIDE
Qilu
November 22, 2023ANDA211871 Podofilox
PODOFILOX
Padagis Us
July 28, 2023ANDA211914 Brinzolamide
BRINZOLAMIDE
Padagis Us
February 11, 2022ANDA212715 Tobramycin and dexamethasone
TOBRAMYCIN AND DEXAMETHASONE
Padagis Us
July 27, 2021ANDA212482 Lidocaine and prilocaine
LIDOCAINE AND PRILOCAINE
Padagis Us
August 4, 2017NDA209478 Spironolactone
CAROSPIR
Cmp Dev LLC
April 6, 2015ANDA204278 Hydromorphone hydrochloride
HYDROMORPHONE HYDROCHLORIDE
Padagis Us
July 15, 2014ANDA205292 Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Padagis Us
June 28, 2013NDA204516 Paroxetine
BRISDELLE
Legacy
May 24, 2013ANDA201291 Trospium chloride
TROSPIUM CHLORIDE
Padagis Us
May 1, 2012ANDA091244 Testosterone cypionate
TESTOSTERONE CYPIONATE
Hikma Farmaceutica
November 17, 2010ANDA091573 Trospium chloride
TROSPIUM CHLORIDE
Padagis Us
January 7, 2009ANDA078266 Ciclopirox
CICLOPIROX
Padagis Us
October 1, 2008ANDA077646 Bromocriptine mesylate
BROMOCRIPTINE MESYLATE
Padagis Us
July 27, 2007NDA022014 Estradiol
EVAMIST
Padagis Us
April 6, 2006NDA021514 Methylphenidate
DAYTRANA
Noven Pharms Inc
October 28, 2005ANDA076763 Clotrimazole
CLOTRIMAZOLE
Padagis Us
May 2, 2005ANDA076379 Midazolam
MIDAZOLAM HYDROCHLORIDE
Padagis Us
January 31, 2005ANDA040530 Testosterone cypionate
TESTOSTERONE CYPIONATE
Padagis Us
December 16, 2004ANDA076831 Flavoxate hydrochloride
FLAVOXATE HYDROCHLORIDE
Padagis Us
January 23, 2004NDA021539 Acetylcysteine
ACETADOTE
Apotex
Show the other 12 applications
ApprovedApplicationMedicineSponsor
June 11, 2002ANDA075589 Tretinoin
TRETINOIN
Padagis Us
January 29, 2002ANDA075600 Podofilox
PODOFILOX
Padagis Us
October 2, 2001NDA021324 Budesonide
ENTOCORT EC
Padagis Us
June 28, 2000ANDA040246 Prochlorperazine
COMPRO
Padagis Us
February 22, 2000ANDA075529 Tretinoin
TRETINOIN
Padagis Us
December 24, 1998ANDA075213 Tretinoin
TRETINOIN
Padagis Us
December 24, 1998ANDA075264 Tretinoin
TRETINOIN
Padagis Us
December 24, 1998ANDA075265 Tretinoin
TRETINOIN
Padagis Us
August 16, 1996ANDA064118 Nystatin
NYSTOP
Padagis Us
January 27, 1994ANDA040062 Methazolamide
METHAZOLAMIDE
Pharmobedient
May 19, 1992NDA020033 Benazepril hydrochloride and hydrochlorothiazide
LOTENSIN HCT
Validus Pharms
October 5, 1981NDA018200 Amiloride
MIDAMOR
Padagis Us

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2023

  1. November 1, 2023 · Class II · Ongoing · D-0139-2024 · Trospium chloride

    Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

    Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand,

  2. February 21, 2023 · Class III · Ongoing · D-0464-2023 · Estradiol

    Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.

    Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan,

2021

  1. March 15, 2021 · Class II · Terminated · D-0549-2021 · Podofilox

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Podofilox Topical Solution 0.5% 3.5ML, Rx Only, For Topical Use Only, Manufactured by Perrigo, Minneapolis, MN 55427, NDC 0574-0611-05.

2018

  1. February 26, 2018 · Class II · Terminated · D-0608-2018 · Estradiol

    Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.

    Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →